Looking Back to Move Forward: The History of PH Care and Research in Canada

Pulmonary hypertension (PH) is no longer the obscure diagnosis it once was. Thanks to decades of research, clinical innovation, and patient advocacy, Canada is now home to world-class PH expertise, growing networks of care, and a resilient, informed patient community.

A new article published in the Canadian Journal of Respiratory Therapy—“History of Respiratory Medicine in Canada: Pulmonary Hypertension”—offers a powerful look at how we got here. Authored by Dr. Sanjay Mehta, and Dr. Namisha Singh, and contributed to by Jamie Myrah, and Dr. Robert D. Levy, the paper chronicles the evolution of PH care and research in Canada and the key players who helped shape it.

From early advances in pulmonary vascular biology to the creation of expert PH centres and national guidelines, the article highlights pivotal moments in our collective journey. It also acknowledges the tireless work of patients, caregivers, and advocates who pushed for better access to treatments, awareness, and support.

This history is more than a timeline—it’s a reminder of the progress we’ve made, and a call to keep building a stronger future for all Canadians affected by PH.

💡 Whether you’re a clinician, researcher, patient, or advocate, this is a must-read look at how far we’ve come—and where we can go from here.

👉 Read the full article